ADAM17 Gene

Aliases
for ADAM17 gene

Previous GC identifers: GC02M009412 GC02M009680 GC02M009651

Summaries
for ADAM17 gene

Genomic Views
for ADAM17 gene

RefSeq DNA sequence:

NC_000002.11  NC_018913.1  NT_005334.16  

SwitchGear Promoter luciferase reporter plasmid: ADAM17 promoter sequence

QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat ADAM17

ADAM17 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)


GeneLoc information about chromosome 2         GeneLoc Exon Structure

GeneLoc location for GC02M009580:  view genomic region     (about GC identifiers)

Proteins
for ADAM17 gene

6/22 PDB 3D structures from and Proteopedia for ADAM17 (see all 22):

1BKC (3D)        1ZXC (3D)        2A8H (3D)        2DDF (3D)        2FV5 (3D)        2FV9 (3D)    

Explore the universe of human proteins at neXtProt for ADAM17: NX_P78536

Post-translational modifications:

	EMD Millipore Purified and/or Recombinant ADAM17 Protein
	R&D Systems Recombinant & Natural Proteins for ADAM17 (TACE/ADAM17)
	Enzo Life Sciences proteins for ADAM17
	Browse OriGene full length recombinant human proteins expressed in human HEK293 cells Browse OriGene Protein Over-expression Lysates OriGene Custom Protein Services for ADAM17
	GenScript Custom Purified and Recombinant Proteins Services for ADAM17
	Novus Biologicals ADAM17 Proteins
	Browse Sino Biological Recombinant Proteins
	Browse ProSpec Recombinant Proteins
	Uscn Proteins for ADAM17

Gene Ontology (GO): 5/10 cellular component terms (GO ID links to tree view) (see all 10):    About this table

	EMD Millipore Mono- and Polyclonal Antibodies for the study of ADAM17
	R&D Systems Antibodies for ADAM17 (TACE/ADAM17)
	Cell Signaling Technology (CST) Antibodies for ADAM17  (TACE)
	OriGene Antibodies (see all 2): ADAM17 OriGene Custom Antibody Services for ADAM17
	GenScript Custom Superior Antibodies Services for ADAM17
	Novus Biologicals ADAM17 Antibodies
	Search for Antibodies for ADAM17 at Abcam
	Uscn Antibodies for ADAM17
	ThermoFisher Antibodies for ADAM17

	Browse Kits and Assays available from EMD Millipore
	OriGene Custom Immunoassay Development Browse OriGene Fluorogenic Cell Assay Kits
	R&D Systems ELISAs for ADAM17 (TACE/ADAM17)         (see all)
	GenScript Custom Assay Services for ADAM17
	Enzo Life Sciences assays for ADAM17
	Uscn ELISAs and CLIAs for ADAM17

Protein Domains /
Families
for ADAM17 gene

ProtoNet protein and cluster: P78536

Function
for ADAM17 gene

miRNA Products:		miRTarBase miRNAs that target ADAM17: hsa-mir-122 (MIRT003112)
		OriGene 3'-UTR Clone: ADAM17 Browse MicroRNA Expression Plasmids
		QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat ADAM17
		8/17 QIAGEN miScript miRNA Assays for microRNAs that regulate ADAM17 (see all 17):
		hsa-miR-140-3p hsa-miR-224 hsa-miR-148b hsa-miR-520d-5p hsa-miR-634 hsa-miR-767-5p hsa-miR-512-3p hsa-miR-507
		SwitchGear 3'UTR luciferase reporter plasmid: ADAM17 3' UTR sequence

Inhib. RNA Products:		Browse for Gene Knock-down Tools from EMD Millipore
		OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for ADAM17 (see all 7) OriGene shRNA RFP: ADAM17 OriGene siRNA: ADAM17
		QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat ADAM17

Gene Editing Products:

DNA2.0 Custom Protein Engineering Service for ADAM17

Clone Products:		Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
		OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for ADAM17 (see all 3) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for ADAM17 (see all 2) OriGene custom cloning services – gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
		GenScript: all cDNA clones in your preferred vector: ADAM17 (NM_003183)
		Browse Sino Biological Human cDNA Clones
		DNA2.0 Custom Codon Optimized Gene Synthesis Service for ADAM17
		Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat ADAM17

Cell Line Products:		GenScript Custom overexpressing Cell Line Services for ADAM17
		Search LifeMap BioReagents cell lines for ADAM17

In Situ Assay Products:

Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for ADAM17

Gene Ontology (GO): 5/8 molecular function terms (GO ID links to tree view) (see all 8):    About this table

15/20 MGI mutant phenotypes (inferred from 11 alleles) (MGI details for Adam17)

Pathways & Interactions
for ADAM17 gene

	Super-pathway	contained gene-specific pathways
1	Signaling by NOTCH1 t(7 9)(NOTCH1:M1580_K2555) Translocation Mutant	8/11 pathways (see all 11) Signaling by NOTCH1 t(7 9)(NOTCH1:M1580_K2555) Translocation Mutant 1.00 Signaling by NOTCH1 1.00 Signaling by NOTCH1 PEST Domain Mutants in Cancer 1.00 Constitutive Signaling by NOTCH1 PEST Domain Mutants 0.79 Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer 1.00 Signaling by NOTCH 0.77 Signaling by NOTCH1 in Cancer 1.00 Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants 0.71
2	NOTCH2 Activation and Transmission of Signal to the Nucleus	Constitutive Signaling by NOTCH1 HD Domain Mutants 0.62 Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor 0.43 Activated NOTCH1 Transmits Signal to the Nucleus 0.58 Constitutive Signaling by NOTCH1 t(7 9)(NOTCH1:M1580_K2555) Translocation Mutant 0.24
3	Development_CNTF receptor signaling	Development_Growth hormone signaling via PI3K/AKT and MAPK cascades 0.34 Immune response_IL-6 signaling pathway 0.30 Development Growth hormone signaling via PI3K/AKT and MAPK cascades 0.34 Immune response IL-6 signaling pathway 0.30
4	Notch Signaling Pathway	Notch Signaling Pathway 1.00 Delta-Notch Signaling Pathway 0.27 Notch signaling pathway 0.82
5	Signaling by FGFR	Signaling by EGFR 0.84 Signalling by NGF 0.52 Signaling by EGFR in Cancer 0.83

4 EMD Millipore Pathways for ADAM17

	Development Growth hormone signaling via PI3K/AKT and MAPK cascades
	Development Notch Signaling Pathway
	Immune response IL-6 signaling pathway
	Development NOTCH1-mediated pathway for NF-KB activity modulation

5/6 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for ADAM17

	Notch Signaling
	Inhibition of Matrix Metalloproteinases
	Molecular Mechanisms of Cancer
	Alzheimers Disease Pathway
	Presenilin-Mediated Signaling

2 Cell Signaling Technology (CST) Pathways for ADAM17

	Wnt / Hedgehog / Notch
	Neuroscience

5 GeneGo (Thomson Reuters) Pathways for ADAM17

	Immune response IL-6 signaling pathway
	Development NOTCH1-mediated pathway for NF-KB activity modulation
	Development Growth hormone signaling via PI3K/AKT and MAPK cascades
	Development Notch Signaling Pathway
	Development MAG-dependent inhibition of neurite outgrowth

5/6 BioSystems Pathways for ADAM17

	Notch Signaling Pathway
	Delta-Notch Signaling Pathway
	Alzheimers Disease
	TNF receptor signaling pathway
	ErbB4 signaling events

5/29        Reactome Pathways for ADAM17

	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
	FBXW7 Mutants and NOTCH1 in Cancer
	Signaling by EGFR in Cancer
	Signaling by NOTCH1 HD Domain Mutants in Cancer
	Signaling by NOTCH1 in Cancer

3         Kegg Pathways  (Kegg details for ADAM17)

	Notch signaling pathway
	Alzheimer's disease
	Epithelial cell signaling in Helicobacter pylori infection

Gene Ontology (GO): 5/35 biological process terms (GO ID links to tree view) (see all 35):    About this table

Drugs & Compounds
for ADAM17 gene

Transcripts
for ADAM17 gene

Expression
for ADAM17 gene

ADAM17 expression in normal human tissues (normalized intensities)
See probesets specificity/sensitivity at GeneAnnot
About this imageBioGPS
CGAP TAG: --

Primer Products:		OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for ADAM17 Browse OriGene validated miRNA SYBR primer pairs
		SABiosciences RT2 qPCR Primer Assay in human, mouse, rat ADAM17
		QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat ADAM17
		QIAGEN QuantiFast Probe-based Assays in human, mouse, rat ADAM17

In Situ Assay Products:

Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for ADAM17

Orthologs
for ADAM17 gene

Paralogs
for ADAM17 gene

Paralogs for ADAM17 gene

ADAM10²  

1 SIMAP similar gene for ADAM17 using alignment to 8 protein entries:     ADA17_HUMAN (see all proteins):

ADAM22

ADAM17 for paralogs           About GeneDecksing

Genomic Variants
for ADAM17 gene

10/1128 NCBI SNPs in ADAM17 are shown (see all 1128)     About this table

Genomic Data					Transcription Related Data				Allele Frequencies
SNP ID	Valid	Clinical significance	Chr 2 pos	Sequence	#	AA Chg	Type	More	#	Allele freq	Pop	Total sample	More
-1st2nd3rd	-1st2nd3rd	-1st2nd3rd	-1st2nd3rd	--	--	--	-1st2nd3rd	--	--	-1st2nd3rd	-1st2nd3rd	-1st2nd3rd
rs1386269561,2		--	9629155(+)	TAATTC/TAAATA	1	--	ds5001		0	--	--	--	--
rs1416991991,2		--	9629200(+)	TATCAA/CGTCTT	1	--	ds5001		0	--	--	--	--
rs1462467971,2		--	9629217(+)	ACAGCC/TCCCAA	1	--	ds5001		0	--	--	--	--
rs1845207381,2		--	9629247(+)	TCTATA/CTCCTG	1	--	ds5001		0	--	--	--	--
rs2014492261,2		--	9629285(+)	TTTTT-/TTGTTTGT	1	--	ds5001		0	--	--	--	--
rs1387888491,2	C,	--	9629298(+)	TGTTG-/TTCTTGTT	1	--	ds5001		0	--	--	--	--
rs1874335891,2		--	9629298(+)	TTGTTC/GTTGTT	1	--	ds5001		0	--	--	--	--
rs1380953501,2		--	9629312(+)	AAATAC/TCTCAC	1	--	ds5001		0	--	--	--	--
rs1417992821,2		--	9629327(+)	TTATTC/TAATAG	1	--	ds5001		0	--	--	--	--
rs1505966401,2		--	9629328(+)	TATTCA/GATAGT	1	--	ds5001		0	--	--	--	--

HapMap Linkage Disequilibrium report for ADAM17 (9628615 - 9695921 bp)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions)
      Database of Genomic Variants (DGV) variations for ADAM17: --
Human Gene Mutation Database (HGMD): ADAM17

SABiosciences Cancer Mutation PCR Assays

QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing ADAM17

DNA2.0 Custom Variant and Variant Library Synthesis for ADAM17

Disorders / Diseases
for ADAM17 gene

20/73 diseases for ADAM17

10/27 Novoseek disease relationships for ADAM17 gene (see all 27)    About this table

Publications
for ADAM17 gene

PubMed articles for ADAM17 gene, integrated from 9 sources (see all 467) (see top 10): (articles sorted by number of sources associating them with ADAM17)

Utopia: connect your pdf to the dynamic world of online information

1. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. (PubMed id 9574564)^{1, 2, 3, 9} Patel I.R.... Amin A.R. (1998)
2. A metalloproteinase disintegrin that releases tumour-necrosis factor- alpha from cells. (PubMed id 9034190)^{1, 2, 3} Black R.A.... Cerretti D.P. (1997)
3. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide. (PubMed id 12621058)^{1, 2, 9} Fan H.... Derynck R. (2003)
4. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. (PubMed id 9034191)^{1, 2, 9} Moss M.L.... Becherer J.D. (1997)
5. Direct activation of TACE-mediated ectodomain sheddin g by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. (PubMed id 20188673)^{1, 2, 9} Xu P. and Derynck R. (2010)
6. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. (PubMed id 9520379)^{1, 2, 9} Maskos K.... Bode W. (1998)
7. Inflammatory skin and bowel disease linked to ADAM17 deletion. (PubMed id 22010916)^{1, 2} Blaydon D.C....Kelsell D.P. (2011)
8. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. (PubMed id 17081983)^{1, 2} Olsen J.V....Mann M. (2006)
9. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. (PubMed id 12441351)^{1, 2} Thathiah A.... Carson D.D. (2003)
10. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. (PubMed id 12058067)^{1, 2} Diaz-Rodriguez E....Pandiella A. (2002)
11. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? (PubMed id 19535569)^{1, 9} Melenhorst W.B....van Goor H. (2009)
12. Sheddase activity of tumor necrosis factor-alpha conv erting enzyme is increased and prognostically valuable in head and neck cancer. (PubMed id 19843672)^{1, 9} Ge L....Vujanovic N.L. (2009)
13. Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. (PubMed id 19299578)^{1, 9} Cesaro A....Hofman P.M. (2009)
14. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. (PubMed id 18600307)^{1, 9} Morange P.E....Tiret L. (2008)
15. Tumor necrosis factor-alpha-converting enzyme as a po tential mediator of the influence of smoking on the response to treatment with narrowband ultraviolet B in psoriasis patients. (PubMed id 20070837)^{1, 9} Serwin A.B....Chodynicka B. (2010)
16. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. (PubMed id 15309730)^{1, 9} Ding X....Lu W.Q. (2004)
17. TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruption. (PubMed id 19082505)^{1, 9} FrAcour T....Masson D. (2009)
18. Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism. (PubMed id 18383040)^{1, 9} Brennan F.M....Takata M. (2008)
19. Tumor necrosis factor-alpha converting enzyme in the human placenta throughout gestation. (PubMed id 18276953)^{1, 9} Hung T.H....Hsieh T.T. (2008)
20. ADAM-17 expression in breast cancer correlates with variables of tumor progression. (PubMed id 17438092)^{1, 9} McGowan P.M....Duffy M.J. (2007)
21. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity. (PubMed id 15102849)^{1, 9} Solomon A....Sagi I. (2004)
22. Impaired regulation of the TNF-alpha converting enzym e/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in hu mans. (PubMed id 19633828)^{1, 9} Monroy A....Folli F. (2009)
23. Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors. (PubMed id 17227756)^{1, 9} Santiago-Josefat B....Arribas J. (2007)
24. Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages. (PubMed id 16210695)^{1, 9} Armstrong L....Millar A.B. (2006)
25. The shedding activity of ADAM17 is sequestered in lipid rafts. (PubMed id 17010968)^{1, 9} Tellier E....Peiretti F. (2006)
26. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. (PubMed id 12755693)^{1, 9} Endres K....Postina R. (2003)
27. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex. (PubMed id 18638486)^{1, 9} Wisniewska M....Bode W. (2008)
28. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. (PubMed id 16148149)^{1, 9} Shao M.X. and Nadel J.A. (2005)
29. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. (PubMed id 14625290)^{1, 9} Cruz A.C....Fang K.C. (2004)
30. Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cells. (PubMed id 14970227)^{1, 9} Bax D.V....Humphries M.J. (2004)
31. ADAM-10 and ADAM-17 in the inflamed human CNS. (PubMed id 12730960)^{1, 9} Kieseier B.C....Hartung H.P. (2003)
32. Effects of biological drug adalimumab on tumour necro sis factor-alpha-converting enzyme activation. (PubMed id 19949420)^{1, 9} Lisi S. and Sisto M. (2010)
33. ADAM17 co-purifies with TIMP-3 and modulates endothel ial invasion responses in three-dimensional collagen matrices. (PubMed id 19666115)^{1, 9} Kwak H.I....Bayless K.J. (2009)
34. HDLs activate ADAM17-dependent shedding. (PubMed id 17786981)^{1, 9} Tellier E....Peiretti F. (2008)
35. Tumour necrosis factor-alpha converting enzyme in human gestational tissues from pregnancies complicated by chorioamnionitis. (PubMed id 16376986)^{1, 9} Hung T.H....Hsieh T.T. (2006)
36. Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. (PubMed id 16641105)^{1, 9} Zhang Q....Grandis J.R. (2006)
37. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome- coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). (PubMed id 15983030)^{1, 9} Lambert D.W.... Turner A.J. (2005)
38. Impaired trafficking and activation of tumor necrosis factor-alpha-converting enzyme in cell mutants defective in protein ectodomain shedding. (PubMed id 12714588)^{1, 9} Borroto A....Arribas J. (2003)
39. ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries--Tampere vascular study. (PubMed id 19253070)^{1, 9} Oksala N....LehtimAoki T. (2009)
40. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme. (PubMed id 15308656)^{1, 9} Lee M.H....Murphy G. (2004)
41. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. (PubMed id 12972643)^{1, 9} Shao M.X....Nadel J.A. (2003)
42. Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. (PubMed id 12706122)^{1, 9} Peiretti F....Nalbone G. (2003)
43. TACE mRNA expression in peripheral mononudear cells precedes new lesions on MRI in multiple sclerosis. (PubMed id 12474981)^{1, 9} Seifert T....Hartung H.P. (2002)
44. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2-beta. (PubMed id 10527948)^{1, 9} Nelson K.K.... Blobel C.P. (1999)
45. Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. (PubMed id 19324423)^{1, 9} Hurst L.A....Woodroofe M.N. (2009)
46. Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor. (PubMed id 19171023)^{1, 9} MAoAottAo J.A....Salmivirta M. (2009)
47. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. (PubMed id 19296470)^{1, 9} Tsai W.C....Tsou A.P. (2009)
48. Expression of tumor necrosis factor alpha converting enzyme in endocrine cancers. (PubMed id 18426733)^{1, 9} Kirkegaard T....Bartlett J.M. (2008)
49. Furin is an endogenous regulator of alpha-secretase associated APP processing. (PubMed id 16942750)^{1, 9} Hwang E.M....Mook-Jung I. (2006)
50. Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNF alpha-converting enzyme activity in airway epithelial cells. (PubMed id 16336275)^{1, 9} Chokki M....Kamimura T. (2005)
51. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme. (PubMed id 16079149)^{1, 9} Wei S....Brew K. (2005)
52. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme. (PubMed id 11988096)^{1, 9} Lee M.H....Murphy G. (2002)
53. ADAM-17: the enzyme that does it all. (PubMed id 20184396)^{1, 9} Gooz M. (2010)
54. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulatio n of TNF-alpha converting enzyme (TACE). (PubMed id 19762488)^{1, 9} Hiasa M....Matsumoto T. (2009)
55. Oxidative stress activates ADAM17/TACE and induces it s target receptor shedding in platelets in a p38-dependent fashion. (PubMed id 19482949)^{1, 9} Brill A....Wagner D.D. (2009)
56. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. (PubMed id 19435795)^{1, 9} Gutwein P....Pfeilschifter J. (2009)
57. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. (PubMed id 18490652)^{1, 9} Haga S....Ishizaka Y. (2008)
58. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. (PubMed id 18355445)^{1, 9} Hiraoka Y....Nishi E. (2008)
59. Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. (PubMed id 18625725)^{1, 9} Wang S.E....Arteaga C.L. (2008)
60. Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17. (PubMed id 17942404)^{1, 9} Ali N. and Knauper V. (2007)
61. Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. (PubMed id 17155946)^{1, 9} Qu D....Esmon C.T. (2007)
62. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. (PubMed id 16982746)^{1, 9} Ringel J....Lohr M. (2006)
63. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase. (PubMed id 16806063)^{1, 9} Cisse M.A....Vincent B. (2006)
64. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). (PubMed id 16332693)^{1, 9} Tsakadze N.L....D'Souza S.E. (2006)
65. The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. (PubMed id 15182369)^{1, 9} Allinson T.M....Hooper N.M. (2004)
66. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. (PubMed id 14532978)^{1, 9} Karan D....Batra S.K. (2003)
67. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. (PubMed id 12743035)^{1, 9} Gschwind A....Ullrich A. (2003)
68. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. (PubMed id 9920899)^{1, 9} Roghani M....Blobel C.P. (1999)
69. Chromosomal assignment of two ADAM genes, TACE (ADAM17) and MLTNB (ADAM19), to human chromosomes 2 and 5, respectively, and of Mltnb to mouse chromosome 11. (PubMed id 9806848)^{1, 9} Hirohata S....Apte S.S. (1998)
70. Lentivirus-mediated ADAM17 RNA interference inhibited interleukin-8 expression via EGFR signaling in lung epithelial cells. (PubMed id 21932060)¹ Li Y....Xia Y. (2012)
71. Lung endothelial ADAM17 regulates the acute inflammato ry response to lipopolysaccharide. (PubMed id 22367719)¹ Dreymueller D....Ludwig A. (2012)
72. Homocysteinylated albumin promotes increased monocyte- endothelial cell adhesion and up-regulation of MCP1, Hsp60 and ADAM17. (PubMed id 22319627)¹ Capasso R....Ingrosso D. (2012)
73. MiR-222 modulates multidrug resistance in human colore ctal carcinoma by down-regulating ADAM-17. (PubMed id 22677042)¹ Xu K....Liu J. (2012)
74. Identification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1. (PubMed id 23105116)¹ Aragao A.Z....Paes Leme A.F. (2012)
75. The cytosolic domain of protein-tyrosine kinase 7 (PTK 7), generated from sequential cleavage by a disintegrin and metalloprotease 17 ( ADAM17) and g-secretase, enhances cell proliferation and migration in colon canc er cells. (PubMed id 22665490)¹ Na H.W....Lee S.T. (2012)
76. Direct observation of proteolytic cleavage at the S2 s ite upon forced unfolding of the Notch negative regulatory region. (PubMed id 23011796)¹ Stephenson N.L. and Avis J.M. (2012)
77. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathwa y activation to promote prostate cancer cell invasion. (PubMed id 22200661)¹ Xiao L.J....Yu X.G. (2012)
78. Unlike for human monocytes after LPS activation, relea se of TNF-a by THP-1 cells is produced by a TACE catalytically different from co nstitutive TACE. (PubMed id 22479555)¹ Moreira-Tabaka H....Muller C.D. (2012)
79. The unfolded protein response controls induction and a ctivation of ADAM17/TACE by severe hypoxia and ER stress. (PubMed id 22105359)¹ Rzymski T....Gorlach A. (2012)
80. Melittin modulates keratinocyte function through P2 re ceptor-dependent ADAM activation. (PubMed id 22613720)¹ Sommer A....Reiss K. (2012)
81. A disintegrin and metalloproteinase 17 (ADAM17) and ep idermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1). (PubMed id 22833676)¹ Breshears L.M....Peterson M.L. (2012)
82. Increased expression of ADAM12 and ADAM17 genes in las er-capture microdissected breast cancers and correlations with clinical and path ological characteristics. (PubMed id 21501859)¹ Narita D....Anghel A. (2012)
83. Formation of the collateral circulation is regulated b y vascular endothelial growth factor-A and a disintegrin and metalloprotease fam ily members 10 and 17. (PubMed id 22965144)¹ Lucitti J.L....Faber J.E. (2012)
84. Interleukin-1 stimulates ADAM17 through a mechanism in dependent of its cytoplasmic domain or phosphorylation at threonine 735. (PubMed id 22384041)¹ Hall K.C. and Blobel C.P. (2012)
85. Role of ADAM10 and ADAM17 in CD16b shedding mediated b y different stimulators. (PubMed id 22770404)¹ Guo S....Zhang W. (2012)
86. Discovery of novel inhibitors of a disintegrin and met alloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates. (PubMed id 22927435)¹ Minond D....Fields G.B. (2012)
87. TACE activation by MAPK-mediated regulation of cell su rface dimerization and TIMP3 association. (PubMed id 22550340)¹ Xu P....Derynck R. (2012)
88. ADAM17 regulates prostate cancer cell proliferation th rough mediating cell cycle progression by EGFR/PI3K/AKT pathway. (PubMed id 21837402)¹ Lin P....Yu X. (2012)
89. ADAM17 promotes glioma cell malignant phenotype. (PubMed id 21480393)¹ Zheng X....Chopp M. (2012)
90. Sjogren's syndrome autoantibodies provoke changes in g ene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-kB. (PubMed id 22157716)¹ Lisi S....D'Amore M. (2012)
91. The membrane-proximal domain of A Disintegrin and Meta lloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 rece ptor and interleukin-1 receptor II. (PubMed id 22575642)¹ Lorenzen I....Grotzinger J. (2012)
92. Differentiation-induced skin cancer suppression by FOS , p53, and TACE/ADAM17. (PubMed id 22772468)¹ Guinea-Viniegra J....Wagner E.F. (2012)
93. Nuclear targeting of IGF-1 receptor in orbital fibrobl asts from Graves' disease: apparent role of ADAM17. (PubMed id 22506015)¹ Hoa N....Smith T.J. (2012)
94. Cell surface annexins regulate ADAM-mediated ectodomai n shedding of proamphiregulin. (PubMed id 22438584)¹ Nakayama H....Higashiyama S. (2012)
95. Proteomic identification of common SCF ubiquitin ligas e FBXO6-interacting glycoproteins in three kinds of cells. (PubMed id 22268729)¹ Liu B....Wang L.S. (2012)
96. Self-control of HGF regulation on human trophoblast ce ll invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17. (PubMed id 22689693)¹ Yang Y....Wang Y.L. (2012)
97. ADAM17 regulates TNFa production by placental trophobl asts. (PubMed id 22018416)¹ Ma R....Wang Y. (2011)
98. Overexpression of TACE and TIMP3 mRNA in head and nec k cancer: association with tumour development and progression. (PubMed id 21102583)¹ Kornfeld J.W....Riethdorf S. (2011)
99. Tumor necrosis factor-I+: investigation of gene polymo rphism and regulation of TACE-TNF-I+ system in patients with acute myocardial in farction. (PubMed id 21153921)¹ Ghaderian S.M....Tabatabaei Panah A.S. (2011)
100. ADAM-17 over-expression in gallbladder carcinoma corr elates with poor prognosis of patients. (PubMed id 20300969)¹ Wu K....Deng Z. (2011)
101. A transforming Src mutant increases the bioavailabili ty of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17 . (PubMed id 20871631)¹ Maretzky T....Blobel C.P. (2011)
102. ADAM12 and ADAM17 gene expression in laser-capture mi crodissected and non-microdissected breast tumors. (PubMed id 21240579)¹ Narita D....Anghel A. (2011)
103. P2Y6 receptors and ADAM17 mediate low-dose gamma-ray- induced focus formation (activation) of EGF receptor. (PubMed id 21268712)¹ Tamaishi N....Kojima S. (2011)
104. Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation. (PubMed id 21949123)¹ Wang Y....Walcheck B. (2011)
105. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. (PubMed id 21407195)¹ Maretzky T....Blobel C.P. (2011)
106. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. (PubMed id 21406692)² Rigbolt K.T....Blagoev B. (2011)
107. TGF-I^1 promotes motility and invasiveness of glioma c ells through activation of ADAM17. (PubMed id 21359495)¹ Lu Y....Chopp M. (2011)
108. ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancer s. (PubMed id 21175594)¹ Sinnathamby G....Philip R. (2011)
109. CCL20/CCR6 feedback exaggerates epidermal growth fact or receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H 292) cells. (PubMed id 21300824)¹ Kim S....Nadel J.A. (2011)
110. ADAM17 (TACE) regulates TGFI^ signaling through the cl eavage of vasorin. (PubMed id 21170088)¹ Malapeira J....Arribas J. (2011)
111. TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells. (PubMed id 21423656)¹ Lemjabbar-Alaoui H....Basbaum C. (2011)
112. Tumor necrosis factor-I+ converting enzyme (TACE) incr eases RANKL expression in osteoblasts and serves as a potential biomarker of pe riodontitis. (PubMed id 21777519)¹ Lee J.H....Cho J.Y. (2011)
113. Reactive oxygen species and p38 mitogen-activated pro tein kinase mediate tumor necrosis factor I+-converting enzyme (TACE/ADAM-17) ac tivation in primary human monocytes. (PubMed id 21865167)¹ Scott A.J....Takata M. (2011)
114. A proteome-wide, quantitative survey of in vivo ubiqui tylation sites reveals widespread regulatory roles. (PubMed id 21890473)¹ Wagner S.A....Choudhary C. (2011)
115. The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. (PubMed id 21365281)¹ GutiAcrrez-LA^pez M.D....CabaA+as C. (2011)
116. Systematic and quantitative assessment of the ubiquiti n-modified proteome. (PubMed id 21906983)¹ Kim W....Gygi S.P. (2011)
117. Epidermal growth factor receptor reactivation induced by E-prostanoid-3 receptor- and tumor necrosis factor-alpha-converting enzyme- dependent feedback exaggerates interleukin-8 production in airway cancer (NCI-H 292) cells. (PubMed id 21925169)¹ Kim S....Nadel J.A. (2011)
118. PKCI+ and PKCI' regulate ADAM17-mediated ectodomain she dding of heparin binding-EGF through separate pathways. (PubMed id 21386996)¹ Kveiborg M....Parker P.J. (2011)
119. Taiwan cobra phospholipase A2 elicits posttranscripti onal up-regulation of ADAM17 in human neuroblastoma SK-N-SH cells. (PubMed id 20506406)¹ Liu W.H....Chang L.S. (2010)
120. Tumor necrosis factor I+-converting enzyme (TACE/ADAM1 7) mediates ectodomain shedding of the scavenger receptor CD163. (PubMed id 20807704)¹ Etzerodt A....Moestrup S.K. (2010)
121. Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality. (PubMed id 20359533)¹ Dusso A....Tokumoto M. (2010)
122. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. (PubMed id 20379614)¹ Rose J.E....Uhl G.R. (2010)
123. Junctional adhesion molecule-C is a soluble mediator of angiogenesis. (PubMed id 20592283)² Rabquer B.J....Koch A.E. (2010)
124. Polymorphisms spanning the TNFR2 and TACE genes do no t contribute towards variable anti-TNF treatment response. (PubMed id 20300049)¹ Potter C....Barton A. (2010)
125. ADAM17 regulates epidermal growth factor receptor exp ression through the activation of Notch1 in non-small cell lung cancer. (PubMed id 20551051)¹ Baumgart A....Dechow T. (2010)
126. Effects of pro-inflammatory cytokines on the producti on of soluble fractalkine and ADAM17 by HepG2 cells. (PubMed id 20922190)¹ Turner S.L....Bunning R.A. (2010)
127. Receptor activator of NF-kappaB (RANK) ligand induces ectodomain shedding of RANK in murine RAW264.7 macrophages. (PubMed id 20118276)¹ Hakozaki A....Toyama Y. (2010)
128. Maternal genes and facial clefts in offspring: a comp rehensive search for genetic associations in two population-based cleft studies from Scandinavia. (PubMed id 20634891)¹ Jugessur A....Murray J.C. (2010)
129. Suppression of ADAM17-mediated Lyn/Akt pathways induc es apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhib itor-like protein-1 uncovers the cytotoxic mechanism. (PubMed id 20679348)¹ Liu W.H. and Chang L.S. (2010)
130. Acetylenic inhibitors of ADAM10 and ADAM17: in silico analysis of potency and selectivity. (PubMed id 20863729)¹ Healy E.F....Lindfors G. (2010)
131. Ectodomain shedding of the Notch ligand Jagged1 is me diated by ADAM17, but is not a lipid-raft-associated event. (PubMed id 20819075)¹ Parr-Sturgess C.A....Parkin E.T. (2010)
132. Ectodomain shedding of Fcalpha receptor is mediated b y ADAM10 and ADAM17. (PubMed id 20059578)¹ Peng M....Zhang W. (2010)
133. Expression of pro-inflammatory TACE-TNF-I+-amphireguli n axis in SjAPgren's syndrome salivary glands. (PubMed id 20811902)¹ Sisto M....D'Amore M. (2010)
134. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. (PubMed id 20068231)² Olsen J.V....Mann M. (2010)
135. ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by gamma-secretase. (PubMed id 20026129)¹ Chalaris A....Scheller J. (2010)
136. Variation at the NFATC2 locus increases the risk of t hiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipr il and rosiglitazone Medication (DREAM) study. (PubMed id 20628086)¹ Bailey S.D....Anand S. (2010)
137. A disintegrin and metalloproteinase 17 (ADAM17) media tes inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells . (PubMed id 19875451)¹ Pruessmeyer J....Ludwig A. (2010)
138. The relationship between ADAM17 promoter polymorphism s and sporadic Alzheimer's disease in a Northern Chinese Han population. (PubMed id 20627730)¹ Wang M....Jia J. (2010)
139. Association of the OCA2 polymorphism His615Arg with m elanin content in east Asian populations: further evidence of convergent evolut ion of skin pigmentation. (PubMed id 20221248)¹ Edwards M....Parra E.J. (2010)
140. Potent arylsulfonamide inhibitors of tumor necrosis f actor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models. (PubMed id 20180536)¹ Nuti E....Rossello A. (2010)
141. The disintegrin-metalloproteinases ADAM 10, 12 and 17 are upregulated in invading peripheral tumor cells of basal cell carcinomas. (PubMed id 19278423)¹ Oh S.T....Reichrath J. (2009)
142. Tumorigenicity of cortical astrocyte cell line induce d by the protease ADAM17. (PubMed id 19515085)¹ Katakowski M....Chopp M. (2009)
143. In situ evidence of involvement of Schwann cells in u lcerative colitis: autocrine and paracrine signaling by A disintegrin and metal loprotease-17-mediated tumor necrosis factor alpha production. (PubMed id 19376560)¹ Mosnier J.F....Laboisse C.L. (2009)
144. Role of ADAMs in the ectodomain shedding and conforma tional conversion of the prion protein. (PubMed id 19564338)¹ Taylor D.R....Hooper N.M. (2009)
145. ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis. (PubMed id 19150341)¹ GAPoz P....Hoffman S. (2009)
146. Gene-centric association signals for lipids and apoli poproteins identified via the HumanCVD BeadChip. (PubMed id 19913121)¹ Talmud P.J.... . (2009)
147. [The two sides of ADAM17 in inflammation: implications in atherosclerosis and obesity] (PubMed id 19154693)¹ Peiretti F....Nalbone G. (2009)
148. Selective use of ADAM10 and ADAM17 in activation of N otch1 signaling. (PubMed id 19704010)¹ Bozkulak E.C. and Weinmaster G. (2009)
149. Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. (PubMed id 19091752)¹ Liu Y....Fassbender K. (2009)
150. Up-regulation of soluble Axl and Mer receptor tyrosin e kinases negatively correlates with Gas6 in established multiple sclerosis les ions. (PubMed id 19541935)¹ Weinger J.G....Shafit-Zagardo B. (2009)
151. Transcription factor Sp1 induces ADAM17 and contribut es to tumor cell invasiveness under hypoxia. (PubMed id 19772640)¹ Szalad A....Chopp M. (2009)
152. UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines. (PubMed id 19003995)¹ Singh B....Ullrich A. (2009)
153. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. (PubMed id 19124506)¹ Mavaddat N....Pharoah P.D. (2009)
154. Vitamin B12 deficiency reduces proliferation and prom otes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE. (PubMed id 19959661)¹ Battaglia-Hsu S.F....GuAcant J.L. (2009)
155. ADAM17_i33708A>G polymorphism interacts with dieta ry n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study. (PubMed id 19819120)¹ Junyent M....OrdovA!s J.M. (2009)
156. TACE-mediated ectodomain shedding of the type I TGF-b eta receptor downregulates TGF-beta signaling. (PubMed id 19595713)¹ Liu C....Derynck R. (2009)
157. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands. (PubMed id 19298600)¹ Nakagawa M....Iwasaki H. (2009)
158. UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes. (PubMed id 18483258)¹ He Y.Y....Chignell C.F. (2008)
159. Toward a confocal subcellular atlas of the human proteome. (PubMed id 18029348)¹ Barbe L....Andersson-Svahn H. (2008)
160. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. (PubMed id 18818406)¹ Swendeman S....Blobel C.P. (2008)
161. Polymorphisms in the tumor necrosis factor/lipopolysaccharides pathway in Crohn disease in the Jewish Ashkenazi population. (PubMed id 18493210)¹ Silbermintz A....Silver J. (2008)
162. Candidate gene/loci studies in cleft lip/palate and dental anomalies finds novel susceptibility genes for clefts. (PubMed id 18978678)¹ Vieira A.R....Marazita M.L. (2008)
163. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients. (PubMed id 18442814)¹ Spinarova L....Vitovec J. (2008)
164. A quantitative atlas of mitotic phosphorylation. (PubMed id 18669648)² Dephoure N.... Gygi S.P. (2008)
165. Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis. (PubMed id 18167350)¹ Paland N....Rudel T. (2008)
166. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease. (PubMed id 18396294)¹ Wang B....Ma X. (2008)
167. Involvement of NF-kappaB-mediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma. (PubMed id 17999917)¹ Takamune Y....Shinohara M. (2008)
168. Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17. (PubMed id 18979631)¹ Esselens C.W....Arribas J. (2008)
169. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. (PubMed id 18636124)¹ Skibola C.F....Smith M.T. (2008)
170. Tumor-associated MICA is shed by ADAM proteases. (PubMed id 18676862)¹ Waldhauer I....Steinle A. (2008)
171. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells. (PubMed id 18373975)¹ Schramme A....Gutwein P. (2008)
172. Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL. (PubMed id 18922903)¹ Van Schaeybroeck S....Longley D.B. (2008)
173. Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. (PubMed id 18713734)¹ Chow J.P....Noda M. (2008)
174. Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. (PubMed id 18824549)¹ Hartl D....Elias J.A. (2008)
175. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer. (PubMed id 18281553)¹ Merchant N.B....Coffey R.J. (2008)
176. ADAM-17 predicts adverse outcome in patients with breast cancer. (PubMed id 18238782)¹ McGowan P.M....Duffy M.J. (2008)
177. Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes. (PubMed id 17714581)¹ Worley J.R....Sampson M.J. (2007)
178. Key feature of the catalytic cycle of TNF-alpha converting enzyme involves communication between distal protein sites and the enzyme catalytic core. (PubMed id 17360351)¹ Solomon A....Sagi I. (2007)
179. TACE: a new target in epidermal growth factor receptor dependent tumors. (PubMed id 17608729)¹ Kenny P.A. (2007)
180. EGF receptor transactivation and PI3-kinase mediate stimulation of ERK by alpha(2A)-adrenoreceptor in intestinal epithelial cells: a role in wound healing. (PubMed id 17655843)¹ Buffin-Meyer B....Paris H. (2007)
181. Metalloproteases and gamma-secretase: new membrane partners regulating p75 neurotrophin receptor signaling? (PubMed id 17986144)¹ Bronfman F.C. (2007)
182. The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. (PubMed id 18171982)¹ Rosso O....Fabbi M. (2007)
183. Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. (PubMed id 17405915)¹ Bachmeier B.E....Boos N. (2007)
184. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing. (PubMed id 16478662)¹ Ruhe J.E....Ullrich A. (2006)
185. Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17. (PubMed id 16912185)¹ Franovic A....Lee S. (2006)
186. FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity. (PubMed id 16619241)¹ Canault M....Peiretti F. (2006)
187. Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. (PubMed id 16900751)¹ Plumb J....Woodroofe M.N. (2006)
188. Alcohol reversibly disrupts TNF-alpha/TACE interactions in the cell membrane. (PubMed id 16246259)¹ Song K....Kolls J.K. (2005)
189. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. (PubMed id 15691827)¹ Rabie T....Nieswandt B. (2005)
190. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. (PubMed id 15784625)¹ Fabre-Lafay S.... Lopez M. (2005)
191. Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases. (PubMed id 16279945)¹ Endres K....Fahrenholz F. (2005)
192. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. (PubMed id 16034137)¹ Gomez M.I....Prince A.S. (2005)
193. Aspirin induces platelet receptor shedding via ADAM17 (TACE). (PubMed id 16179345)¹ Aktas B....Nieswandt B. (2005)
194. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. (PubMed id 15534001)¹ Williams C.C....Jones F.E. (2004)
195. A cellular metalloproteinase activates Vibrio cholerae pro-cytolysin. (PubMed id 15066987)¹ Valeva A....Zitzer A. (2004)
196. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands. (PubMed id 15280379)¹ Tanaka M....Higashiyama S. (2004)
197. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. (PubMed id 15146197)¹ Brandenberger R.... Stanton L.W. (2004)
198. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. (PubMed id 15337756)¹ Schafer B....Ullrich A. (2004)
199. Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. (PubMed id 12711607)¹ Lemjabbar H....Basbaum C. (2003)
200. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). (PubMed id 12832423)¹ Matthews V....Rose-John S. (2003)
201. Identification of SAP97 as an intracellular binding partner of TACE. (PubMed id 12668732)¹ Peiretti F....Nalbone G. (2003)
202. Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. (PubMed id 12810728)¹ Contin C....Dechanet-Merville J. (2003)
203. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. (PubMed id 12947092)¹ Le Gall S.M....Mauduit P. (2003)
204. TACE is required for the activation of the EGFR by TGF-alpha in tumors. (PubMed id 12606576)¹ Borrell-Pages M....Arribas J. (2003)
205. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. (PubMed id 12777399)¹ Fourie A.M....Karlsson L. (2003)
206. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. (PubMed id 12535668)¹ Asai M....Ishiura S. (2003)
207. Mechanisms by which gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR). (PubMed id 12568494)¹ Basbaum C....Lemjabbar H. (2002)
208. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. (PubMed id 12135369)¹ Mohan M.J....Milla M.E. (2002)
209. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3. (PubMed id 12044879)¹ Lee M.H....Murphy G. (2002)
210. Tumor necrosis factor-alpha converting enzyme. (PubMed id 11733179)¹ Black R.A. (2002)
211. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. (PubMed id 11741929)¹ Poghosyan Z....Edwards D.R. (2002)
212. Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. (PubMed id 12207026)¹ Zheng Y....Blobel C.P. (2002)
213. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. (PubMed id 11823465)¹ Sunnarborg S.W....Lee D.C. (2002)
214. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. (PubMed id 12147693)¹ Gomez-Gaviro M.V....Diaz-Gonzalez F. (2002)
215. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)¹ Strausberg R.L....Marra M.A. (2002)
216. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. (PubMed id 10799478)¹ English W.R....Murphy G. (2000)
217. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. (PubMed id 10860581)¹ Karkkainen I....Huovila A.P. (2000)
218. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. (PubMed id 10882063)¹ Brou C....Israel A. (2000)
219. The Protein Data Bank. (PubMed id 10592235)⁷ Berman H.M....Bourne P.E. (2000)
220. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. (PubMed id 10433800)¹ Cerretti D.P....Nelson N. (1999)
221. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. (PubMed id 10224132)¹ Lum L....Blobel C.P. (1999)
222. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amylo id protein precursor. (PubMed id 9774383)¹ Buxbaum J.D....Black R.A. (1998)
223. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. (PubMed id 9620803)¹ Schroeter E.H....Kopan R. (1998)
224. Normalization and subtraction: two approaches to facilitate gene discovery. (PubMed id 8889548)¹ Bonaldo M.F.... Soares M.B. (1996)
225. ADAM17 promotes breast cancer cell malignant phenotyp e through EGFR-PI3K-AKT activation. (PubMed id 19395875)⁹ Zheng X....Chopp M. (2009)
226. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain. (PubMed id 15100227)⁹ Gonzales P.E....Milla M.E. (2004)
227. Induction of TNF-alpha-converting enzyme-ectodomain s hedding by pathogenic autoantibodies. (PubMed id 19854762)⁹ Sisto M....D'Amore M. (2009)
228. Identification of key sequence determinants for the inhibitory function of the prodomain of TACE. (PubMed id 18707126)⁹ Gonzales P.E....Milla M.E. (2008)
229. Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells. (PubMed id 14678276)⁹ Kirkegaard T....Brynskov J. (2004)
230. Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch. (PubMed id 15749738)⁹ Buckley C.A....Levine S.J. (2005)
231. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. (PubMed id 10385500)⁹ Satoh M....Hiramori K. (1999)
232. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. (PubMed id 15556048)⁹ Satoh M....Hiramori K. (2004)
233. Porphyromonas gingivalis stimulates TACE production by T cells. (PubMed id 19239642)⁹ Bostanci N....Belibasakis G.N. (2009)
234. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells. (PubMed id 16041691)⁹ Blanchot-Jossic F....Mosnier J.F. (2005)
235. Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis. (PubMed id 15888146)⁹ Kawaguchi M....Kondo S. (2005)
236. ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. (PubMed id 15923650)⁹ Soond S.M....Murphy G. (2005)
237. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. (PubMed id 15206946)⁹ Bzowska M....Bereta J. (2004)
238. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-alpha converting enzyme (TACE). (PubMed id 15075334)⁹ Li X. and Fan H. (2004)
239. Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis. (PubMed id 11028485)⁹ Satoh M....Hiramori K. (2000)
240. Regulation of mature ADAM17 by redox agents for L-selectin shedding. (PubMed id 19201900)⁹ Wang Y....Walcheck B. (2009)
241. ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma. (PubMed id 17180679)⁹ Takamune Y....Shinohara M. (2007)
242. The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: possible contribution to elevated plasma levels of soluble TNF alpha receptors. (PubMed id 16214147)⁹ Canault M....Nalbone G. (2006)
243. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis. (PubMed id 11508576)⁹ Ohta S....Kamatani N. (2001)
244. cDNA cloning of mouse tumor necrosis factor-alpha converting enzyme (TACE) and partial analysis of its promoter. (PubMed id 10375622)⁹ Mizui Y....Tanaka I. (1999)
245. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha. (PubMed id 19767822)⁹ Hikita A....Fukui N. (2009)
246. ADAM17 as a therapeutic target in multiple diseases. (PubMed id 19601834)⁹ Arribas J. and Esselens C. (2009)
247. The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction. (PubMed id 18226043)⁹ Satoh M....Nakamura M. (2008)
248. The transmembrane domain of TACE regulates protein ectodomain shedding. (PubMed id 18040288)⁹ Li X....Fan H. (2007)
249. TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis. (PubMed id 16511637)⁹ Comabella M....Montalban X. (2006)
250. Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction. (PubMed id 15603556)⁹ Shimoda Y....Hiramori K. (2005)
251. Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro. (PubMed id 15556967)⁹ Robertshaw H.J. and Brennan F.M. (2005)
252. Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm. (PubMed id 14580234)⁹ Satoh H....Hiramori K. (2004)
253. Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway. (PubMed id 14751236)⁹ Villanueva de la Torre T....Arribas J. (2004)
254. Application of peptides containing the cleavage sequence of pro-TNFalpha in assessing TACE activity of whole cells. (PubMed id 12530549)⁹ Becker B.F....Zahler S. (2002)
255. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. (PubMed id 11156944)⁹ Zhang Z....Kolls J.K. (2001)
256. ADAM-17 is activated by the mitogenic protein kinase ERK in a model of kidney fibrosis. (PubMed id 20087163)⁹ Bell H.L. and GAPAPz M. (2010)
257. LRP1 shedding in human brain: roles of ADAM10 and ADAM17. (PubMed id 19371428)⁹ Liu Q....Bu G. (2009)
258. Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains. (PubMed id 19234765)⁹ Bernstein H.G....Reiser G. (2009)
259. Multiple shRNA-mediated knockdown of TACE reduces the malignancy of HeLa cells. (PubMed id 18996214)⁹ Yan Y....Yang Y.Z. (2009)
260. Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM17 and its proteolytic substrate L-selectin. (PubMed id 17928459)⁹ Schaff U....Walcheck B. (2008)
261. Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing. (PubMed id 18991041)⁹ Sakimoto T....Sawa M. (2008)
262. Tumor necrosis factor-alpha-converting enzyme (TACE) levels in periodontal diseases. (PubMed id 18296613)⁹ Bostanci N....Belibasakis G.N. (2008)
263. Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells. (PubMed id 16799629)⁹ Obeid D....Bauvois B. (2007)
264. Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels. (PubMed id 16762326)⁹ Marshall A.J....Vaughan P.F. (2006)
265. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. (PubMed id 16737974)⁹ Gooz M....Raymond J.R. (2006)
266. IK682, a tight binding inhibitor of TACE. (PubMed id 16762314)⁹ Niu X....Orth P. (2006)
267. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. (PubMed id 15641051)⁹ Franchimont N....Malaise M. (2005)
268. [Screening of TACE peptide inhibitors from a phage display random 15-peptide library by recombinant TACE ecotodomain] (PubMed id 15859325)⁹ Huang W....Yang Y.Z. (2005)
269. Gene expression profiles of TNF-alpha, TACE, furin, IL-1beta and matrilysin in UVA- and UVB-irradiated HaCat cells. (PubMed id 15998365)⁹ Skiba B....Piva T.J. (2005)
270. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybu tanamide, a potent and selective inhibitor of TNF-alpha converting enzyme. (PubMed id 15531300)⁹ Zhang Y....Levin J. (2004)
271. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. (PubMed id 12849708)⁹ Ermert M....Ermert L. (2003)
272. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. (PubMed id 11277930)⁹ Itai T....Nagata S. (2001)
273. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase. (PubMed id 11162616)⁹ Lee M.H....Murphy G. (2001)
274. ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. (PubMed id 11334139)⁹ Condon T.P....Bennett C.F. (2001)
275. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. (PubMed id 10799547)⁹ Reddy P....Black R.A. (2000)
276. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. (PubMed id 10510344)⁹ Solomon K.A....Newton R.C. (1999)
277. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). (PubMed id 10521439)⁹ Milla M.E....Becherer J.D. (1999)
278. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. (PubMed id 9733803)⁹ Merlos-Suarez A....Arribas J. (1998)
279. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. (PubMed id 19995578)⁹ Haga S....Ishizaka Y. (2010)
280. Substitution of methionine 435 with leucine, isoleucine, and serine in tumor necrosis factor alpha converting enzyme inactivates ectodomain shedding activity. (PubMed id 17464354)⁹ Perez L....Fan H. (2007)
281. [Inhibition of proliferation, adhesion and invasion ability of human lung carcinoma cell A549 by tumor necrosis factor-alpha converting enzyme (TACE)] (PubMed id 17822026)⁹ Yan Y....Yang Y.Z. (2007)
282. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. (PubMed id 17884817)⁹ Charbonneau M....Dubois C.M. (2007)
283. The TACE zymogen: re-examining the role of the cysteine switch. (PubMed id 16679521)⁹ Milla M.E....Leonard J.D. (2006)
284. Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain. (PubMed id 16399672)⁹ Lomniczi A....Ojeda S.R. (2006)
285. Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. (PubMed id 16724341)⁹ Bandyopadhyay S....Rogers J.T. (2006)
286. Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-alpha release in patients with severe peritonitis: role of tumor necrosis factor-alpha converting enzyme cleavage. (PubMed id 15942356)⁹ Kermarrec N....Chollet-Martin S. (2005)
287. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. (PubMed id 14659806)⁹ Gilles S....Becker B.F. (2003)
288. Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). (PubMed id 9042103)⁹ Moss M.L....Willard D. (1997)
289. The discovery of novel tartrate-based TNF-alpha conve rting enzyme (TACE) inhibitors. (PubMed id 20022498)⁹ Rosner K.E....Strickland C.O. (2010)
290. Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3. (PubMed id 19292764)⁹ Armstrong L....Millar A.B. (2009)
291. Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). (PubMed id 17368021)⁹ Sheppeck J.E....Duan J.J. (2007)
292. Comparison of properties of tumor necrosis factor-alp ha converting enzyme (TACE) and some matrix metalloproteases (MMPs) in catalyti c domains. (PubMed id 17357475)⁹ Zhao Y....Chen R. (2006)
293. Human colonic myocytes are involved in postischemic inflammation through ADAM17-dependent TNFalpha production. (PubMed id 16273118)⁹ Jarry A....Laboisse C.L. (2006)
294. Janus kinase 2 influences growth hormone receptor metalloproteolysis. (PubMed id 16497804)⁹ Loesch K....Frank S.J. (2006)
295. Localization of tumour necrosis factor-alpha converting enzyme in normal human skin. (PubMed id 14987279)⁹ Kawaguchi M....Kondo S. (2004)
296. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. (PubMed id 15121636)⁹ Shao M.X....Nadel J.A. (2004)
297. Acute alcohol inhibits TNF-alpha processing in human monocytes by inhibiting TNF/TNF-alpha-converting enzyme interactions in the cell membrane. (PubMed id 12626543)⁹ Zhao X.J....Kolls J.K. (2003)
298. Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis. (PubMed id 10849774)⁹ Gottschalk C....Ansorge S. (2000)
299. New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors. (PubMed id 10579851)⁹ Barlaam B....Maciewicz R. (1999)
300. [Screening of ADAMs that can mediate the generation o f soluble MHC I] (PubMed id 20306608)⁹ Zhao J.R. and Yan Z. (2010)
301. The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding. (PubMed id 20331435)⁹ Killock D.J. and IvetiA8 A. (2010)
302. Tumor necrosis factor-alpha converting enzyme: Implic ations for ocular inflammatory diseases. (PubMed id 20303413)⁹ Ramana K.V. (2010)
303. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. (PubMed id 19131941)⁹ Hoareau L....Roche R. (2009)
304. ATP-mediated activation of the NADPH oxidase DUOX1 me diates airway epithelial responses to bacterial stimuli. (PubMed id 19386603)⁹ Boots A.W....van der Vliet A. (2009)
305. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells. (PubMed id 18971959)⁹ Anderegg U....Simon J.C. (2009)
306. The role of ADAMs in disease pathophysiology. (PubMed id 19408347)⁹ Duffy M.J....McGowan P.M. (2009)
307. Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells. (PubMed id 18171996)⁹ Zhuang S....Schnellmann R.G. (2008)
308. Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines. (PubMed id 18452483)⁹ Itabashi H....Masuda T. (2008)
309. Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients. (PubMed id 17868246)⁹ Teles R.M....Sarno E.N. (2007)
310. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies. (PubMed id 17207628)⁹ Dehmel T....Kieseier B.C. (2007)
311. Metalloproteases regulate T-cell proliferation and effector function via LAG-3. (PubMed id 17245433)⁹ Li N....Vignali D.A. (2007)
312. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. (PubMed id 17895248)⁹ Moss M.L....Zhou P. (2007)
313. ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains. (PubMed id 17027649)⁹ Thiel K.W. and Carpenter G. (2006)
314. Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292. (PubMed id 16427093)⁹ Chokki M....Kamimura T. (2006)
315. Effects of anoxia and hypoxia on amyloid precursor protein processing in cerebral microvascular smooth muscle cells. (PubMed id 16783171)⁹ Auerbach I.D. and Vinters H.V. (2006)
316. Therapeutic potential of TACE inhibitors in stroke. (PubMed id 15857301)⁹ Lovering F. and Zhang Y. (2005)
317. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition. (PubMed id 14734567)⁹ Lee M.H....Murphy G. (2004)
318. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. (PubMed id 15034047)⁹ von Tresckow B....Hansen H.P. (2004)
319. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S) thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis. (PubMed id 14718605)⁹ Zhang Y....Lin L.L. (2004)
320. Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors. (PubMed id 12951101)⁹ Letavic M.A....Yu C.H. (2003)
321. Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity. (PubMed id 14587281)⁹ Black R.A....Paxton R. (2003)
322. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. (PubMed id 14587283)⁹ Murphy G....Williamson R. (2003)
323. Shedding of membrane proteins by ADAM family proteases. (PubMed id 12463167)⁹ Moss M.L. and Lambert M.H. (2002)
324. [Effect of reduqing on HL-60 cells in secreting tumor necrosis factor alpha production and on TNF alpha converting enzyme mRNA expre ssion] (PubMed id 12577359)⁹ Wang K.F....Yang Y.Z. (2001)
325. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). (PubMed id 11495925)⁹ Garton K.J....Raines E.W. (2001)
326. Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. (PubMed id 10818238)⁹ Wang K.Y....Sasaguri Y. (2000)
327. Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha. (PubMed id 10669637)⁹ Imaizumi T....Satoh K. (2000)
328. (PubMed id 18395853)⁹ 
329. ADAMs and protein disulfide isomerase: the key to reg ulated cell-surface protein ectodomain shedding? (PubMed id 20504280)⁹ Bass R. and Edwards D.R. (2010)
330. Novel TACE inhibitors in drug discovery: a review of patented compounds. (PubMed id 20021284)⁹ Murumkar P.R....Yadav M.R. (2010)
331. Cell-cell interaction promotes rat marrow stromal cel l differentiation into endothelial cell via activation of TACE/TNF-alpha signal ing. (PubMed id 19796498)⁹ Xu J....Liu Z. (2010)
332. Expression profiles and clinical correlations of degr adome components in the tumor microenvironment of head and neck squamous cell c arcinoma. (PubMed id 20305301)⁹ Stokes A....KAohAori V.M. (2010)
333. TNF-alpha-converting enzyme (TACE/ADAM17)-dependent l oss of CD30 induced by proteasome inhibition through reactive oxygen species. (PubMed id 19890373)⁹ Vahdat A.M....Hansen H.P. (2010)
334. Release of soluble tumor necrosis factor receptor 1 f rom corneal epithelium by TNF-alpha-converting enzyme-dependent ectodomain shed ding. (PubMed id 19407014)⁹ Sakimoto T....Sawa M. (2009)
335. The regulation of TACE catalytic function by its prod omain. (PubMed id 18386160)⁹ Li X....Chang L. (2009)
336. Chimeric form of tumor necrosis factor-alpha has enhanced surface expression and antitumor activity. (PubMed id 18654609)⁹ Rieger R....Kipps T.J. (2009)
337. Current perspective of TACE inhibitors: a review. (PubMed id 19095454)⁹ DasGupta S....Yadav M.R. (2009)
338. Reconstitution of amphiregulin-epidermal growth facto r receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. (PubMed id 19825997)⁹ Gilmore J.L....Foley J. (2009)
339. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. (PubMed id 19250983)⁹ Yan F....Polk D.B. (2009)
340. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. (PubMed id 18658095)⁹ Yin J. and Yu F.S. (2009)
341. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. (PubMed id 19411314)⁹ Jia H.P....McCray P.B. (2009)
342. TIMP3 is reduced in atherosclerotic plaques from subj ects with type 2 diabetes and increased by SirT1. (PubMed id 19581416)⁹ Cardellini M....Federici M. (2009)
343. Role of ADAMs in cancer formation and progression. (PubMed id 19228719)⁹ Duffy M.J....McGowan P.M. (2009)
344. CB-12181, a new azasugar-based matrix metalloproteina se/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular e ndothelial growth factor-induced angiogenesis in vitro and retinal neovasculari zation in vivo. (PubMed id 19534723)⁹ Chikaraishi Y....Hara H. (2009)
345. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. (PubMed id 19147560)⁹ Wang S.E....Arteaga C.L. (2009)
346. Identification of five candidate lung cancer biomarke rs by proteomics analysis of conditioned media of four lung cancer cell lines. (PubMed id 19776420)⁹ Planque C....Diamandis E.P. (2009)
347. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. (PubMed id 18621108)⁹ Candelario-Jalil E....Rosenberg G.A. (2009)
348. Prediction of novel and selective TNF-alpha convertin g enzyme (TACE) inhibitors and characterization of correlative molecular descri ptors by machine learning approaches. (PubMed id 19729328)⁹ Cong Y....Xue Y. (2009)
349. Minireview: Pref-1: role in adipogenesis and mesenchy mal cell fate. (PubMed id 19541743)⁹ Sul H.S. (2009)
350. The ADAM metalloproteinases. (PubMed id 18762209)⁹ Edwards D.R....Pennington C.J. (2008)
351. Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach. (PubMed id 18822146)⁹ McEachin R.C....McInnis M.G. (2008)
352. Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production. (PubMed id 18021299)⁹ Tachida Y....Hashimoto Y. (2008)
353. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes. (PubMed id 18471442)⁹ Qureshi H.Y....Zafarullah M. (2008)
354. Production of the soluble form of KIT, s-KIT, abolish es stem cell factor-induced melanogenesis in human melanocytes. (PubMed id 18239612)⁹ Kasamatsu S....Boissy R.E. (2008)
355. Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents. (PubMed id 18282708)⁹ Lu Z....Duan J.J. (2008)
356. mGluR1/5-dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE. (PubMed id 18367087)⁹ Cho R.W....Worley P.F. (2008)
357. RNA interference silencing of DRAL affects processing of amyloid precursor protein. (PubMed id 18534756)⁹ Tanahashi H. and Yoshioka K. (2008)
358. Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cells. (PubMed id 18487372)⁹ Cook E.B....Barney N.P. (2008)
359. Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular chondrocytes. (PubMed id 17546624)⁹ El Mabrouk M....Zafarullah M. (2008)
360. Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). (PubMed id 18234496)⁹ Ott G.R....Duan J.J. (2008)
361. PI3-K- and PKC-dependent up-regulation of APP processing enzymes by retinoic acid. (PubMed id 17986385)⁹ Holback S....Iverfeldt K. (2008)
362. Role of metalloproteinases in platelet function. (PubMed id 17681591)⁹ Santos-Martinez M.J....Radomski M.W. (2008)
363. p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidine. (PubMed id 18390808)⁹ Deng X....Roth R.A. (2008)
364. SEB-induced signaling in macrophages leads to biphasic TNF-alpha. (PubMed id 18364436)⁹ Khan A.A....Saha B. (2008)
365. Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite. (PubMed id 17283047)⁹ Chen J....Harris R.C. (2007)
366. Expression and protein chemistry yielding crystallization of the catalytic domain of ADAM17 complexed with a hydroxamate inhibitor. (PubMed id 17169570)⁹ Hoth L.R....Geoghegan K.F. (2007)
367. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. (PubMed id 17504810)⁹ Wu S....Sears C.L. (2007)
368. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. (PubMed id 17945434)⁹ Peng Y....Lemere C.A. (2007)
369. Endoplasmic reticulum-associated degradation of growth hormone receptor in Janus kinase 2-deficient cells. (PubMed id 17761766)⁹ Loesch K....Frank S.J. (2007)
370. The signaling pathway involved in neutrophil elastase stimulated MUC1 transcription. (PubMed id 17600314)⁹ Kuwahara I....Kim K.C. (2007)
371. Innate immune mucin production via epithelial cell surface signaling: relationship to allergic disease. (PubMed id 17218812)⁹ Nadel J.A. (2007)
372. Extracellular phosphorylation of collagen XVII by ecto-casein kinase 2 inhibits ectodomain shedding. (PubMed id 17545155)⁹ Zimina E.P....Bruckner-Tuderman L. (2007)
373. Targeting TACE-dependent EGFR ligand shedding in breast cancer. (PubMed id 17218988)⁹ Kenny P.A. and Bissell M.J. (2007)
374. Regulation of interleukin-8 via an airway epithelial signaling cascade. (PubMed id 17220369)⁹ Nakanaga T....Shao M.X. (2007)
375. ADAMs in cancer cell proliferation and progression. (PubMed id 17355265)⁹ Mochizuki S. and Okada Y. (2007)
376. Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening. (PubMed id 17548045)⁹ Moss M.L. and Rasmussen F.H. (2007)
377. Emerging targets of biologic therapies for rheumatoid arthritis. (PubMed id 17538565)⁹ Tarner I.H....Gay S. (2007)
378. Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. (PubMed id 17376651)⁹ Qureshi H.Y....Zafarullah M. (2007)
379. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. (PubMed id 17913923)⁹ Hoe H.S....Rebeck G.W. (2007)
380. Three-dimensional extracellular matrix culture models of EGFR signalling and drug response. (PubMed id 17635116)⁹ Kenny P.A. (2007)
381. Evidence of a role of tumor necrosis factor alpha in refractory asthma. (PubMed id 16481637)⁹ Berry M.A....Pavord I.D. (2006)
382. Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling? (PubMed id 16910760)⁹ Ungvari Z....Csiszar A. (2006)
383. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. (PubMed id 16229685)⁹ Stoeck A....Altevogt P. (2006)
384. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme. (PubMed id 16923819)⁹ Nishi E....Kita T. (2006)
385. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. (PubMed id 16806998)⁹ Wang C.T....Hou S.M. (2006)
386. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. (PubMed id 16401770)⁹ Fedak P.W....Li R.K. (2006)
387. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. (PubMed id 16840716)⁹ Ohtsu H....Eguchi S. (2006)
388. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. (PubMed id 16497166)⁹ Heidinger M....Ries C. (2006)
389. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. (PubMed id 16221845)⁹ LesnAc S....Buisson A. (2005)
390. Continuous real-time measurement of tumor necrosis fa ctor-alpha converting enzyme activity on live cells. (PubMed id 16127421)⁹ Alvarez-Iglesias M....Takata M. (2005)
391. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. (PubMed id 15913581)⁹ AnnAc W....HeidbA1chel H. (2005)
392. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. (PubMed id 15647744)⁹ Pradillo J.M....Lizasoain I. (2005)
393. Inhibitors of TACE and Caspase-1 as anti-inflammatory drugs. (PubMed id 16378499)⁹ Le G.T. and Abbenante G. (2005)
394. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping. (PubMed id 16101009)⁹ Lambert M.H....Moss M.L. (2005)
395. Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells. (PubMed id 15731011)⁹ Peiretti F....Nalbone G. (2005)
396. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. (PubMed id 15787600)⁹ Hooper N.M. (2005)
397. The non-amyloidogenic pathway: structure and function of alpha-secretases. (PubMed id 15709475)⁹ Kojro E. and Fahrenholz F. (2005)
398. N-terminal cleavage of proTGFalpha occurs at the cell surface by a TACE-independent activity. (PubMed id 15777285)⁹ Juanes P.P....Pandiella A. (2005)
399. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. (PubMed id 15640347)⁹ Shao M.X. and Nadel J.A. (2005)
400. Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13. (PubMed id 15911259)⁹ Noe M.C....Tokar C. (2005)
401. Chaperone-like properties of the prodomain of TNFalph a-converting enzyme (TACE) and the functional role of its cysteine switch. (PubMed id 15581423)⁹ Leonard J.D....Milla M.E. (2005)
402. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma. (PubMed id 16002728)⁹ Bohlson S.S....Tenner A.J. (2005)
403. Distinct roles of EGF repeats for the Notch signaling system. (PubMed id 15561108)⁹ Sakamoto K....Yamaguchi A. (2005)
404. Expression of TNFalpha and its receptors R1 and R2 in human alveolar epithelial cells exposed to organic dust and the effects of 8-bromo-cAMP and protein kinase A modulation. (PubMed id 16134057)⁹ Burvall K....Larsson K. (2005)
405. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme. (PubMed id 15713681)⁹ Lee M.H....Murphy G. (2005)
406. Screening of TACE peptide inhibitors from phage displ ay peptide library. (PubMed id 16463648)⁹ Huang W....Yang Y. (2005)
407. c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. (PubMed id 15887294)⁹ Edwards S.T....Fang K.C. (2005)
408. Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. (PubMed id 16221290)⁹ Kurz M....Kieseier B.C. (2005)
409. Soluble tumor necrosis factor (TNF) receptor-1 induce s apoptosis via reverse TNF signaling and autocrine transforming growth factor- beta1. (PubMed id 15514103)⁹ Waetzig G.H....Schreiber S. (2005)
410. Structure of angiotensin I-converting enzyme. (PubMed id 15549168)⁹ Sturrock E.D....Acharya K.R. (2004)
411. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. (PubMed id 15492278)⁹ Kokkinakis D.M....Luo J. (2004)
412. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. (PubMed id 14699008)⁹ Diwan A....Mann D.L. (2004)
413. Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. (PubMed id 15319441)⁹ Koon H.W....Pothoulakis C. (2004)
414. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. (PubMed id 15128827)⁹ Abel S....Ludwig A. (2004)
415. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. (PubMed id 15197174)⁹ Nagano O....Saya H. (2004)
416. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. (PubMed id 14715932)⁹ Suzuki T....Nakata Y. (2004)
417. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. (PubMed id 15199050)⁹ Argast G.M....Fausto N. (2004)
418. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. (PubMed id 15345652)⁹ Bergmeier W....Wagner D.D. (2004)
419. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. (PubMed id 15142990)⁹ Thathiah A....Carson D.D. (2004)
420. Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution. (PubMed id 15284022)⁹ Myhre G.M....Egan L.J. (2004)
421. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. (PubMed id 14594449)⁹ Kruse M.N....StAPcker W. (2004)
422. Chronic ethanol enhances ectodomain shedding in T cells and monocytes. (PubMed id 15365312)⁹ Zhao X.J....Kolls J.K. (2004)
423. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. (PubMed id 12957613)⁹ de Jonge N....de Weger R.A. (2003)
424. Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. (PubMed id 12605594)⁹ Akatsu T....Hiramori K. (2003)
425. Identification of a selectivity determinant for inhibition of tumor necrosis factor-alpha converting enzyme by comparative modeling. (PubMed id 12670535)⁹ Wasserman Z.R....Decicco C.P. (2003)
426. Design strategies for the identification of MMP-13 and Tace inhibitors. (PubMed id 14579524)⁹ Skotnicki J.S....Levin J.I. (2003)
427. Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors. (PubMed id 12723945)⁹ Cherney R.J....Decicco C.P. (2003)
428. Phorbol 12-myristate 13-acetate-induced ectodomain shedding and phosphorylation of the human meprinbeta metalloprotease. (PubMed id 12941954)⁹ Hahn D....Sterchi E.E. (2003)
429. Mechanism of three inhibitors of TACE in blocking the converting of pro-TNF alpha into sTNF alpha. (PubMed id 12973924)⁹ Wang Z....Yang Y. (2003)
430. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. (PubMed id 12789686)⁹ Supuran C.T....Scozzafava A. (2003)
431. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme. (PubMed id 12556225)⁹ Lee M.H....Murphy G. (2003)
432. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. (PubMed id 14623079)⁹ Srour N....Dubois C.M. (2003)
433. Metalloproteinases and the modulation of GH signaling. (PubMed id 12208655)⁹ Baumann G. and Frank S.J. (2002)
434. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. (PubMed id 12384559)⁹ Scotton C.J....Balkwill F.R. (2002)
435. Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils. (PubMed id 12488495)⁹ TaA^eb J....Chollet-Martin S. (2002)
436. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening. (PubMed id 14599359)⁹ Chen Y....Busch S.J. (2002)
437. The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion. (PubMed id 12224947)⁹ Cross J.B....Madison V.S. (2002)
438. Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha. (PubMed id 11939793)⁹ Parkin E.T....Hooper N.M. (2002)
439. Effect of tumor necrosis factor-alpha converting enzy me (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons. (PubMed id 12472889)⁹ Blacker M....LeBlanc A.C. (2002)
440. Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation. (PubMed id 11934805)⁹ Trifilieff A....Neumann U. (2002)
441. Tumor necrosis factor-alpha-converting enzyme: its role in community-acquired pneumonia. (PubMed id 12447765)⁹ Greene C....O'Neill S. (2002)
442. Inhibition of metalloproteinases enhances the interna lization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunoto xin. (PubMed id 11857410)⁹ Hansen H.P....Lemke H. (2002)
443. The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process. (PubMed id 12226103)⁹ Grantcharova E....Oksche A. (2002)
444. Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. (PubMed id 11238737)⁹ Lopez-Perez E....Checler F. (2001)
445. Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme. (PubMed id 11677124)⁹ Holms J....Davidsen S. (2001)
446. Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. (PubMed id 11595838)⁹ Mannello F. and Gazzanelli G. (2001)
447. Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. (PubMed id 11536196)⁹ Skovronsky D.M....Milla M.E. (2001)

External Searches for ADAM17 gene

Genome Databases showing ADAM17 gene

Other Databases showing ADAM17 gene

Specialized Databases showing ADAM17 gene

Products
for ADAM17 gene